Conventional memory T cells develop as naïve T cells in the thymus and become activated in the periphery by recognition of foreign antigen in an inflammatory context (i.e. infection) ( and ). Innate CD8
+ T cells phenotypically resemble memory T cells, yet do not require antigen experience to obtain this status, demonstrated by the fact that OT-I
Rag−/− cells adopt a memory phenotype and function when present as bystander cells in KLF2-deficient mixed bone marrow chimeras [
16]. In this regard, innate CD8
+ T cells resemble homeostatic (or virtual) memory T cells [
51], which are generated in peripheral lymphoid organs in lymphopenic animals, in response to IL-7, IL-15 and self MHC-peptide [
52,
53] ( and ). On the other hand, innate CD8
+ T cells develop in the thymus in an IL-4 dependent manner (and presumably in response to self MHC-peptide). Are these 3 subsets of memory cells functionally equivalent? Certainly the fact that homeostatic and innate memory CD8
+ T cells do not require foreign antigen recognition for their generation means that that they are unlikely to play a critical role in secondary infections as do conventional memory CD8
+ T cells that were clonally expanded during a primary response (). However, there is growing evidence for an “innate” role of memory CD8
+ T cells in primary infections, as sensors of an inflammatory environment [
54]. For example, conventional memory OT-I T cells can produce IFNγ early on during infection with pathogens that do not encode the ovalbumin antigen [
55]. This response could be induced by IL-12 and IL-18 produced by activated myeloid cells [
54,
56,
57]. Furthermore, this response is protective, at least in the context where no other cells can produce IFNγ [
55]. Both homeostatic and innate CD8+ memory cells also produce IFNγ in response to IL-12 and IL-18 [
17,
51]. Therefore it would seem most likely that homeostatic memory and innate CD8
+ T cells play roles early during infection, via production of IFNγ. In the human immune system, these types of non-conventional or unprimed CD8
+ T cells could be important as they are able to participate in host defense during the neonatal and early childhood period before conventional memory networks are established [
1,
16,
26].
Whereas conventional memory CD8
+ T cells are composed of heterogenous subsets expressing T-bet and Eomes [
58], innate CD8
+ T cells selectively express Eomes. There is a complex interplay between Eomes and T-bet in the generation of central and effector memory responses, with expression of T-bet being generally associated with good effector responses [
14], and Eomes with long-lived memory responses. Therefore, the lifespan and role of innate CD8
+ T cells in the development of protective immunity remains to be investigated.
IL-4 is not typically associated with the generation of protective CD8
+ T cell responses. The ability of IL-4 to drive expression of Eomes, CXCR3, and IFNγ production in CD8
+ T cells is counterintuitive, given its role in CD4 helper responses, where it promotes a Th2 response, and suppresses a T-bet-mediated Th1 response [
59]. However, the effect of IL-4 on CD8
+ T cells is not without precedent in the literature. Complexes of IL-4–anti-IL-4 drive the proliferation of CD8
+ T cells [
36,
60]. In fact, IL-4 is a potent growth factor for memory CD8
+ T cells at doses produced during normal immune responses [
36]. In addition, IL-4 supports the proliferation [
61] and conversion of naïve CD8
+ T cells into memory phenotype CD8 T cells in lymphopenic mice [
62].
There is an important role for IL-4 in the development of CD8
+ T cell protective anti-malaria immunity, in which IL-4R deficient CD8
+ T cells specific for circumsporozoite protein of
Plasmodium yoelii fail to develop into tissue-residing memory cells [
63,
64]. Interestingly, wild type BALB/c mice are much more effective than C57BL/6 strains at controlling malaria pathogens after immunization with radiation inactivated forms of
P. berghei or P. yoelii sporozoites [
65], which might be related to the high frequency of innate CD8
+ T cells in the BALB/c strain.